What is Leerink Partnrs’ Estimate for BOLT Q1 Earnings?
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2026 earnings per share (EPS) estimates for Bolt Biotherapeutics in a report issued on Tuesday, March 25th. Leerink Partnrs analyst D. Graybosch forecasts that the company will post earnings of ($0.36) per share for the quarter. The consensus estimate […]
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2026 earnings per share (EPS) estimates for Bolt Biotherapeutics in a report issued on Tuesday, March 25th. Leerink Partnrs analyst D. Graybosch forecasts that the company will post earnings of ($0.36) per share for the quarter. The consensus estimate […]
